|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation, amortization and accretion | |||||
| Net loss on disposal of property and equipment, net of insurance recoveries, and impairment expense | |||||
| Share-based compensation | |||||
| Bad debt expense | |||||
| Change in fair value of earnout liability | |||||
| Change in fair value of warrant liabilities | |||||
| Paid-in-kind interest, amortization of deferred debt issuance costs, net of capitalized interest | |||||
| Gain on sales-type lease | |||||
| Write off of equity issuance costs | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable, net | |||||
| Receivables from related parties | |||||
| Prepaids and other current assets and other assets | |||||
| Operating lease assets and liabilities, net | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Customer deposits | |||||
| Other current and noncurrent liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from sale-leaseback transaction | |||||
| Proceeds from sale-leaseback transactions | |||||
| Proceeds from insurance for property losses | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from long-term debt | |||||
| Proceeds from capital-build funding | |||||
| Contribution from redeemable noncontrolling interest | |||||
| Payments of withholding tax on net issuance of restricted stock units | |||||
| Payments of deferred debt issuance costs | |||||
| Proceeds from issuance of Class A common stock | |||||
| ATM | |||||
| Equity Offering | |||||
| Payments of deferred equity issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Total cash, cash equivalents and restricted cash, beginning of year | |||||
| End of year | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, noncurrent | |||||
| Total cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental cash flow data | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosure of noncash investing and financing activities | |||||
| Fair value adjustment to redeemable noncontrolling interest | |||||
| Non-cash adjustments to redeemable noncontrolling interest | |||||
| Capital expenditures in accounts payable and accrued liabilities | |||||
| Non-cash increase in capital-build | |||||
| Deferred debt issuance costs in accounts payable, accrued liabilities, other current liabilities and other liabilities | |||||
| Paid-in-kind interest | |||||
| Property and equipment recognized upon termination of a sales-type lease | |||||
| Interest capitalized to property, equipment and software | |||||
| Property and equipment derecognized for net investment in sales-type lease | |||||
| Non-cash increase in asset retirement obligations | |||||
| Asset retirement obligations incurred | |||||
| Deferred debt issuance costs in accounts payable and accrued liabilities | |||||
| Share-based compensation capitalized to property, equipment and software | |||||
| Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets | |||||
| Beginning of year | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
Loading...